India Juris advises on acquisition of Saitech Medicare

31 January 2010

Protech Biosystems “Protech” is India’s highly progressive health management company involved in research, manufacturing and marketing of branded and generic pharmaceutical formulations. Protech Biosystems exports to Russia & CIS countries, South East Asia, African countries, Latin American countries.

India Juris assisted the Protech in acquisition of majority stakes in Chandigarh, India based pharma company Saitech Medicare Pvt Ltd. The complex transaction involved due diligence, corporate law advise, advise on capital gain tax, shareholders agreements and various other side letters, transfer of registrations and approvals etc.

The transaction was successfully completed to the satisfaction of the client.

News & Deals

India Juris Signs MoU with NLU Meghalaya

India Juris Supports USD 7 Million Series A Funding

India Juris Supports USD 2.5 Million Seed Investment in AI

Publications

Children’s Data and Verifiable Parental Consent

Comparative Energy Security – China and India

Setting Up a Fund in GIFT City, IFSC

Newsletters

SEBI Revises Credit Risk & Trustee Compliance Norms

Product Liability & Regulatory Developments

DPDP Act: Key Compliance Updates